1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 411 Novel intratumoral agent, INT230–6 induces cancer cell death, increases tumor infiltrates and results in durable benefit alone or in combination with pembrolizumab in refractory patients. (9th November 2020) Authors: El-Khoueiry, Anthony; Thomas, Jacob; Olszanski, Anthony; Azad, Nilofer; Bender, Lewis; Walters, Ian; Whalen, Giles; Hanna, Diana; Ingham, Matthew; Siu, Lilian Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 411 Novel intratumoral agent, INT230–6 induces cancer cell death, increases tumor infiltrates and results in durable benefit alone or in combination with pembrolizumab in refractory patients. (9th November 2020) Authors: El-Khoueiry, Anthony; Thomas, Jacob; Olszanski, Anthony; Azad, Nilofer; Bender, Lewis; Walters, Ian; Whalen, Giles; Hanna, Diana; Ingham, Matthew; Siu, Lilian Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Arc-produced short-length multi-walled carbon nanotubes as "millstones" for the preparation of graphene-like nanoplatelets. (May 2019) Authors: Kostoglou, Nikolaos; Ryzhkov, Vladislav; Walters, Ian; Doumanidis, Charalabos; Rebholz, Claus; Mitterer, Christian Journal: Carbon Issue: Volume 146(2019) Page Start: 779 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. INT230-6 shows strong synergy with anti-PD-1 and can induce high complete response rates with T cell memory response in a colon cancer mouse model. Issue 2 (December 2015) Authors: Bloom, Anja; Bender, Lewis; Terabe, Masaki; Berzofsky, Jay; Walters, Ian Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Intratumorally delivered formulation, INT230-6, containing potent anticancer agents induces protective T cell immunity and memory. (3rd October 2019) Authors: Bloom, Anja C.; Bender, Lewis H.; Tiwary, Shweta; Pasquet, Lise; Clark, Katharine; Jiang, Tianbo; Xia, Zheng; Morales-Kastresana, Aizea; Jones, Jennifer C.; Walters, Ian; Terabe, Masaki; Berzofsky, Jay A. Journal: Oncoimmunology Issue: Volume 8:Number 10(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours. (October 2019) Authors: Jones, Robin L.; Ratain, Mark J.; O'Dwyer, Peter J.; Siu, Lillian L.; Jassem, Jacek; Medioni, Jacques; DeJonge, Maja; Rudin, Charles; Sawyer, Michael; Khayat, David; Awada, Ahmad; de Vos-Geelen, Judith M.P.G.M.; Evans, T.R. Jeffry; Obel, Jennifer; Brockstein, Bruce; DeGreve, Jacques; Baurain, Jea... Journal: European journal of cancer Issue: Volume 120(2019) Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Quality of life in patients with K‐RAS wild‐type colorectal cancer. Issue 2 (11th October 2013) Authors: Ringash, Jolie; Au, Heather‐Jane; Siu, Lillian L.; Shapiro, Jeremy D.; Jonker, Derek J.; Zalcberg, John R.; Moore, Malcolm J.; Strickland, Andrew; Kotb, Rami; Jeffery, Mark; Alcindor, Thierry; Ng, Siobhan; Salim, Muhammad; Sabesan, Sabe; Easaw, Jay C.; Shannon, Jenny; El‐Tahche, Fabyolla; Walters... Journal: Cancer Issue: Volume 120:Issue 2(2014) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Quality of life in patients with K‐RAS wild‐type colorectal cancer: The CO.20 Phase 3 Randomized Trial. Issue 2 (11th October 2013) Authors: Ringash, Jolie; Au, Heather‐Jane; Siu, Lillian L.; Shapiro, Jeremy D.; Jonker, Derek J.; Zalcberg, John R.; Moore, Malcolm J.; Strickland, Andrew; Kotb, Rami; Jeffery, Mark; Alcindor, Thierry; Ng, Siobhan; Salim, Muhammad; Sabesan, Sabe; Easaw, Jay C.; Shannon, Jenny; El‐Tahche, Fabyolla; Walters... Journal: Cancer Issue: Volume 120:Issue 2(2014) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗